Unknown OBSERVATIONAL NCT01877902

Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM

Sponsor: Fundación Pública Andaluza Progreso y Salud

Conditions Carcinoma, Non-Small-Cell Lung

Updated 8 times since 2017 Last updated: Dec 4, 2014 Started: Oct 31, 2011 Primary completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Carcinoma, Non-Small-Cell Lung, this trial is ongoing. The trial is conducted by Fundación Pública Andaluza Progreso y Salud and has accumulated 8 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Feb 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Feb 2020 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Pública Andaluza Progreso y Salud

Data source: Andalusian Network for Design and Translation of Advanced Therapies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Algeciras, Spain , Almería, Spain , Baza, Spain , Cadiz, Spain , Córdoba, Spain , Granada, Spain , Huelva, Spain , Jerez de la Frontera, Spain , Marbella, Spain , Málaga, Spain and 2 more locations